Hypoglycemia surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
* Enucleation of the insulinoma  
* Enucleation of the insulinoma  
* Partial distal pancreatectomy  
* Partial distal pancreatectomy  
* Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.37
* Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.<ref name="pmid1684067">{{cite journal| author=Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH| title=Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 998-1004; discussion 1004-5 | pmid=1684067 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1684067  }}</ref>
* Recurrence is more common in the patients with MEN1.
* Recurrence is more common in the patients with MEN1.
* Hepatic resection is indicated for the treatment of metastatic liver disease if general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.
* Hepatic resection is indicated for the treatment of metastatic liver disease if general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.

Revision as of 13:51, 19 July 2017

Hypoglycemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypoglycemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypoglycemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypoglycemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypoglycemia surgery

CDC on Hypoglycemia surgery

Hypoglycemia surgery in the news

Blogs on Hypoglycemia surgery

Directions to Hospitals Treating Hypoglycemia

Risk calculators and risk factors for Hypoglycemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Surgery

  • Surgical removal of the insulinoma is the treatment of choice:[1]
  • Enucleation of the insulinoma
  • Partial distal pancreatectomy
  • Distal subtotal pancreatectomy is recommended for patients with insulinoma related to MEN1.[2]
  • Recurrence is more common in the patients with MEN1.
  • Hepatic resection is indicated for the treatment of metastatic liver disease if general condition is good. Resection should be considered only for patients with a limited number of hepatic metastases.

References

  1. Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin Proc. 66 (7): 711–9. PMID 1677058.
  2. Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH (1991). "Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach". Surgery. 110 (6): 998–1004, discussion 1004-5. PMID 1684067.


Template:WikiDoc Sources